Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE

Clinical trial NCT00687609 · TERMINATED

Trial details

NCT number: NCT00687609
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder Cannabis Abuse

Start date: 2008-09-01
Primary completion: 2009-06-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.